These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9814723)

  • 21. Statistics review 3: hypothesis testing and P values.
    Whitley E; Ball J
    Crit Care; 2002 Jun; 6(3):222-5. PubMed ID: 12133182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [CONSORT--what a proper scientific publication should supply].
    Windeler J; Koch A
    Med Klin (Munich); 2000 May; 95(1 Spec No):91-7. PubMed ID: 10851855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statistics in medical journals: some recent trends.
    Altman DG
    Stat Med; 2000 Dec; 19(23):3275-89. PubMed ID: 11113959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Post-hoc data analysis: benefits and limitations.
    Curran-Everett D; Milgrom H
    Curr Opin Allergy Clin Immunol; 2013 Jun; 13(3):223-4. PubMed ID: 23571411
    [No Abstract]   [Full Text] [Related]  

  • 25. Putting Meaning Back Into the Mean: A Comment on the Misuse of Elementary Statistics in a Sample of Manuscripts Submitted to Clinical Therapeutics.
    Forrester JE
    Clin Ther; 2015 Dec; 37(12):2614-8. PubMed ID: 26626608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reporting number needed to treat and absolute risk reduction in randomized controlled trials.
    Nuovo J; Melnikow J; Chang D
    JAMA; 2002 Jun; 287(21):2813-4. PubMed ID: 12038920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. University of Pennsylvania 12th annual conference on statistical issues in clinical trials: Electronic health records in randomized clinical trials-challenges and opportunities (morning panel session).
    Esserman D; Goldstein BA; Levenson M; Platt R; Roe MT; Zeliadt S
    Clin Trials; 2020 Aug; 17(4):405-413. PubMed ID: 32615793
    [No Abstract]   [Full Text] [Related]  

  • 28. Show the data, don't conceal them.
    Drummond GB; Vowler SL
    Adv Physiol Educ; 2011 Jun; 35(2):130-2. PubMed ID: 21652496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in the ethos of medical publications as reflected in progressive alterations in the uniform requirements for manuscripts submitted to biomedical journals (1979-2008).
    Kojima T; Barron JP
    Chest; 2010 Jun; 137(6):1479-82. PubMed ID: 20525661
    [No Abstract]   [Full Text] [Related]  

  • 30. Issues of study design and data analysis.
    D'Agostino RB
    Inflamm Bowel Dis; 1998 May; 4(2):109-111; discussion 111-3. PubMed ID: 9687216
    [No Abstract]   [Full Text] [Related]  

  • 31. Presenting graphical information.
    Bryant TN
    Pediatr Allergy Immunol; 1999 Feb; 10(1):4-13. PubMed ID: 10410911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endorsement of the CONSORT guidelines, trial registration, and the quality of reporting randomised controlled trials in leading nursing journals: A cross-sectional analysis.
    Jull A; Aye PS
    Int J Nurs Stud; 2015 Jun; 52(6):1071-9. PubMed ID: 25540865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single-factor repeated-measures designs: analysis and interpretation.
    Gliner JA; Morgan GA; Harmon RJ
    J Am Acad Child Adolesc Psychiatry; 2002 Aug; 41(8):1014-6. PubMed ID: 12162619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose response studies. II. Analysis and interpretation.
    Ruberg SJ
    J Biopharm Stat; 1995 Mar; 5(1):15-42. PubMed ID: 7613559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Easily applicable multiple testing procedures to improve the interpretation of clinical trials with composite endpoints.
    Schüler S; Mucha A; Doherty P; Kieser M; Rauch G
    Int J Cardiol; 2014 Jul; 175(1):126-32. PubMed ID: 24861257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A cautionary tale: dealing with missing data in clinical trials for rheumatic diseases.
    Song J; Boscardin WJ; Furst DE; Khanna D; Wong WK
    Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-122-6. PubMed ID: 25372798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How to deal with multiple treatment or dose groups in randomized clinical trials?
    Hothorn LA
    Fundam Clin Pharmacol; 2007 Apr; 21(2):137-54. PubMed ID: 17391286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessing assumptions for statistical analyses in randomised clinical trials.
    Nielsen EE; Nørskov AK; Lange T; Thabane L; Wetterslev J; Beyersmann J; de Uña-Álvarez J; Torri V; Billot L; Putter H; Winkel P; Gluud C; Jakobsen JC
    BMJ Evid Based Med; 2019 Oct; 24(5):185-189. PubMed ID: 30948454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Statistics must be seen and scrutinized! Fundamental to the progress of medical science--yet neglected in medical journals].
    Taube A
    Lakartidningen; 2002 Dec; 99(51-52):5176-9. PubMed ID: 12572313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing quality of reports on randomized clinical trials in nursing journals.
    Parent N; Hanley JA
    Can J Cardiovasc Nurs; 2009; 19(2):25-39. PubMed ID: 19517902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.